We draw lessons from immunization research by assessing the applicability of the 5C framework of vaccine hesitancy to contraceptive acceptability in sub-Saharan Africa.
View Article and Find Full Text PDFCervical cancer rates in Sub-Saharan Africa (SSA) are amongst the highest worldwide. All three of the Human Papillomavirus (HPV) vaccines (9-valent, quadrivalent and bivalent HPV vaccine) provide primary protection against the most common cancer-causing strains of HPV (types 16 and 18) that are known to cause 70% of cervical cancers. Over the last five years, there has been an increase in Sub-Saharan African countries that have introduced the HPV vaccine.
View Article and Find Full Text PDFBackground: Tuberculosis remains a major public health problem in poverty-stricken areas of the world. Communal gathering places account for the majority of TB transmission in high burden settings.
Objective: To investigate the social behaviour patterns of individuals who have developed TB disease and adolescents at risk of infection.